Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 4
2002 1
2003 2
2004 5
2005 1
2006 2
2007 2
2008 2
2009 3
2011 4
2013 5
2014 7
2015 5
2016 14
2017 7
2018 15
2019 22
2020 16
2021 13
2022 15
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Duodenal disorder"
Page 1
Bariatric surgery: a systematic review and meta-analysis.
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Buchwald H, et al. JAMA. 2004 Oct 13;292(14):1724-37. doi: 10.1001/jama.292.14.1724. JAMA. 2004. PMID: 15479938 Review.
CONTEXT: About 5% of the US population is morbidly obese. This disease remains largely refractory to diet and drug therapy, but generally responds well to bariatric surgery. ...The mean (95% confidence interval) percentage of excess weight loss was 61.2% (58.1%-64.4%) for …
CONTEXT: About 5% of the US population is morbidly obese. This disease remains largely refractory to diet and drug therapy, but gener …
A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases: A systematic review and meta-analysis.
Simadibrata DM, Syam AF, Lee YY. Simadibrata DM, et al. J Gastroenterol Hepatol. 2022 Dec;37(12):2217-2228. doi: 10.1111/jgh.16017. Epub 2022 Oct 26. J Gastroenterol Hepatol. 2022. PMID: 36181401 Free PMC article.
METHODS: We searched up to June 5, 2022, for randomized controlled trials of gastric acid-related diseases that included erosive esophagitis, symptomatic gastroesophageal reflux disease (GERD), peptic ulcers, and Helicobacter pylori infection. ...There were no differences …
METHODS: We searched up to June 5, 2022, for randomized controlled trials of gastric acid-related diseases that included erosive esophagitis …
Surgery for weight loss in adults.
Colquitt JL, Pickett K, Loveman E, Frampton GK. Colquitt JL, et al. Cochrane Database Syst Rev. 2014 Aug 8;2014(8):CD003641. doi: 10.1002/14651858.CD003641.pub4. Cochrane Database Syst Rev. 2014. PMID: 25105982 Free PMC article. Review.
Effects on comorbidities, complications and additional surgical procedures were neutral, except gastro-oesophageal reflux disease improved following LRYGB (one RCT). One RCT of people with a BMI 25 to 35 and type 2 diabetes found laparoscopic mini-gastric bypass resulted i …
Effects on comorbidities, complications and additional surgical procedures were neutral, except gastro-oesophageal reflux disease imp …
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.
Lima JJ, Thomas CD, Barbarino J, Desta Z, Van Driest SL, El Rouby N, Johnson JA, Cavallari LH, Shakhnovich V, Thacker DL, Scott SA, Schwab M, Uppugunduri CRS, Formea CM, Franciosi JP, Sangkuhl K, Gaedigk A, Klein TE, Gammal RS, Furuta T. Lima JJ, et al. Clin Pharmacol Ther. 2021 Jun;109(6):1417-1423. doi: 10.1002/cpt.2015. Epub 2020 Sep 20. Clin Pharmacol Ther. 2021. PMID: 32770672 Free PMC article.
Proton pump inhibitors (PPIs) are widely used for acid suppression in the treatment and prevention of many conditions, including gastroesophageal reflux disease, gastric and duodenal ulcers, erosive esophagitis, Helicobacter pylori infection, and pathological hypers …
Proton pump inhibitors (PPIs) are widely used for acid suppression in the treatment and prevention of many conditions, including gastroesoph …
Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials.
Visaggi P, Ghisa M, Barberio B, Maniero D, Greco E, Savarino V, Black CJ, Ford AC, de Bortoli N, Savarino E. Visaggi P, et al. Dig Liver Dis. 2023 Feb;55(2):208-222. doi: 10.1016/j.dld.2022.05.004. Epub 2022 May 30. Dig Liver Dis. 2023. PMID: 35654734 Free article. Review.
BACKGROUND: Eosinophilic gastrointestinal diseases (EGIDs) are chronic inflammatory disorders of the gut, including eosinophilic esophagitis (EoE), gastritis (EoG), duodenitis (EoD), gastroenteritis (EoGE), and colitis (EoC). ...
BACKGROUND: Eosinophilic gastrointestinal diseases (EGIDs) are chronic inflammatory disorders of the gut, including eosinophilic esop …
Organ at Risk Dose Constraints in SABR: A Systematic Review of Active Clinical Trials.
Gerhard SG, Palma DA, Arifin AJ, Louie AV, Li GJ, Al-Shafa F, Cheung P, Rodrigues GB, Bassim CW, Corkum MT. Gerhard SG, et al. Pract Radiat Oncol. 2021 Jul-Aug;11(4):e355-e365. doi: 10.1016/j.prro.2021.03.005. Pract Radiat Oncol. 2021. PMID: 34217495
We sought to evaluate OAR dose constraints used in ongoing clinical trials of SABR for oligometastatic disease. METHODS AND MATERIALS: Clinicaltrials.gov was searched from inception to February 2020 to capture actively accruing clinical trials using SABR in oligometastatic …
We sought to evaluate OAR dose constraints used in ongoing clinical trials of SABR for oligometastatic disease. METHODS AND MATERIALS …
Helicobacter pylori infection.
Leontiadis GI, Moayyedi P, Ford AC. Leontiadis GI, et al. BMJ Clin Evid. 2009 Oct 1;2009:0406. BMJ Clin Evid. 2009. PMID: 21718575 Free PMC article. Review.
METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of H pylori eradication treatment in people with a confirmed duodenal ulcer, a confirmed gastric ulcer, confirmed gastro-oesophageal reflux …
METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of H pylor …
Duodenal Eosinophils and Mast Cells in Functional Dyspepsia: A Systematic Review and Meta-Analysis of Case-Control Studies.
Shah A, Fairlie T, Brown G, Jones MP, Eslick GD, Duncanson K, Thapar N, Keely S, Koloski N, Shahi M, Walker MM, Talley NJ, Holtmann G. Shah A, et al. Clin Gastroenterol Hepatol. 2022 Oct;20(10):2229-2242.e29. doi: 10.1016/j.cgh.2022.01.014. Epub 2022 Feb 3. Clin Gastroenterol Hepatol. 2022. PMID: 35123088 Review.
BACKGROUND & AIMS: This study explored the link between duodenal eosinophils and mast cells in patients with functional dyspepsia (FD). ...No significant difference in duodenal eosinophils was seen according to FD subtypes. CONCLUSIONS: This meta-analysis sugges …
BACKGROUND & AIMS: This study explored the link between duodenal eosinophils and mast cells in patients with functional dyspepsia …
Rofecoxib for osteoarthritis.
Garner SE, Fidan DD, Frankish R, Maxwell L. Garner SE, et al. Cochrane Database Syst Rev. 2005 Jan 25;2005(1):CD005115. doi: 10.1002/14651858.CD005115. Cochrane Database Syst Rev. 2005. PMID: 15654705 Free PMC article. Review.
Further information is available at www.vioxx.com. Osteoarthritis is a chronic disease of the joints, characterised by joint pain, stiffness and loss of physical function. ...Endoscopic studies indicated that compared to ibuprofen 800 mg three times a day, rofecoxib caused …
Further information is available at www.vioxx.com. Osteoarthritis is a chronic disease of the joints, characterised by joint pain, st …
142 results